Merck & Company: Product KL-798 (SPANISH...
Frey, Sherwood C. ...
Merck & Company: Product KL-798 (SPANISH)
Frey, Sherwood C. Jr.; Bodily, Samuel E.
QA-0910 | Published October 11, 2017 | 5 pages Case
Collection: Darden School of Business
Product Details
This is a Spanish translation of the June 14, 2016, version of UVA-QA-0582. Merck has been approached by a small biotech research firm with the proposal that Merck buy the rights to a new drug that promises to treat obesity and lower cholesterol. The drug is in the middle of phase I of the FDA approval process. Pat Harlow, the chief licensing officer, has been leading Merck's investigation team. A meeting is scheduled for tomorrow at which Merck's response to the offer will be drafted.
0
Products to Upsell
Chains
Larson, Andrea
Terminal Values, Multiples, and Competit...
Harris, Robert S.
Leading with Vulnerability
Belmi, Peter; Thom...
Accounting for Owners’ Equity
Lynch, Luann J.; B...
Share Repurchases
Loutskina, Elena
Finance People
Schill, Michael J.
Ought to "Can": Questions for an Entrepr...
Sarasvathy, Saras ...
Jonathan Virginia, Inc.
Hess, Edward D.